Blodprov kan ge supertidig upptäckt av Parkinsons sjukdom

Ny forskning ledd från Chalmers öppnar möjligheter att via blodprov upptäcka Parkinsons sjukdom i dess allra tidigaste skede, innan större hjärnskador har skett.

CTC Clinical Trial Consultants AB

Multiplex immunofluorescence chemistries with ZEISS tissue multiplexing workflow

Bringing leading multiplex immunofluorescence chemistries together in one automated 8-channel imaging platform.

FDA tar nya steg mot att fasa ut djurförsök

Amerikanska läkemedelsmyndigheten FDA har presenterat ett utkast till vägledning för djurförsök, som kan innebära ett skifte i hur prekliniska säkerhetsstudier ...

Acquisition of consulting company Key2Compliance

The Swedish company Key2Compliance, offering services in fields such as pharma and Medtech, has been acquired by German GBA Group.

AstraZeneca´s Trixeo approved in the UK using propellant with near-zero Global Warming Potential

AstraZeneca has received approval in the United Kingdom for its inhaled respiratory medicine Trixeo Aerosphere with a new propellant that is reported to reduce ...

FDA approves Gilead’s HIV injection: “Historic day”

Gilead Sciences’ preventive HIV drug, lenacapavir, was approved on Wednesday by the U.S. Food and Drug Administration (FDA), sparking new hope for finally break...

Matti Sällberg om året som kommer: ”Större intresse riktas mot Europa”

Nu nalkas vinterns ledigheter. Det vill Life Science Sweden uppmärksamma genom att ställa bakåt- och framåtblickande frågor till branschprofiler fram till jul. ...

ZEISS unveils AI-powered Research Data Platform

Collaboration with Boehringer Ingelheim champions the future of personalized eye care.

Vd-byte i Frost Pharma

Frost Pharma har utsett Magnus Nylén till ny vd.

Galderma

Kennedy attackerar dansk vaccinstudie – ”Propagandanummer från läkemedelsindustrin”

USA:s hälsominister Robert F. Kennedy Jr. uppmanar en medicinsk tidskrift att dra tillbaka publiceringen av en stor vaccinstudie, vars slutsatser han ogillar. M...

“Research is always a lot of failures and a few successes”

Gene therapies open up fantastic possibilities, but they are also extremely expensive to produce. Genenova aims to change that and make the treatments accessibl...

ZEISS continues to drive digital era forward in ophthalmology

2 million digitally planned cataract cases in the U.S. alone.

SGS Fimko Ltd.

Automated dispensing of a viscous hydrogel

A suitable solution developed for UPM Biomedicals In the Festo LifeTech Application Center we tested a setup for UPM Biomedicals for the automatic dispensing of...

Positive EMA Decision for BioArctic's New Drug Candidate

Bioarctic's drug candidate for multiple system atrophy, exidavnemab, is recommended to be classified as an orphan drug, according to the European Medicines Agency (EMA).

How to Assure Quality within R&D Medical Devices

Free webinar on June 3rd, 2025, 9:00 - 9:45 AM CEST and 5:00 - 5:45 PM CEST.

ZEISS introduces the new Smartzoom 100

The future of digital microscopy for efficient optical inspections.

Sex lanseringar ska dubbla Sobi – ”Fyra potentiella blockbusters”

Läkemedelsbolaget Sobi siktar på att fördubbla sina intäkter till 55 miljarder kronor till år 2030. Bakom tillväxtplanen står sex lanseringar, varav fyra bedöms...

Truly Labs AB

Optimize Courier SUPPLIERS (DISTRIBUTORS)

Icelandic pharmaceutical company Alvotech to list on Nasdaq Stockholm

One of Iceland's largest companies, the pharmaceutical firm Alvotech, has announced its intention to list on Nasdaq Stockholm.

Mikael Kubista back with new venture after turbulent exit

Entrepreneur and researcher Mikael Kubista is starting a new company. Now he is also free to comment on the sequence of events that led to him losing ownership ...